ArticleCells2026

Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma.

Kristina Živić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.